CIK 0001638097
- Non-accelerated filer
- Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 25327151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Burshtein Gregory Chief of R&D | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2026-05-07 | Burshtein Gregory Chief of R&D | Grant or award | +87,591 | 189,033 | ||
| 2025-07-16 | Burshtein Gregory Chief of R&D | Grant or award | +26,316 | 101,442 | ||
| 2025-07-16 | Burshtein Gregory Chief of R&D | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 |
Page 1 of 1 · 4 trades